Loading...

Symptomatic Rebound Hypercalcemia After Denosumab Discontinuation in a Pediatric Patient With Cherubism

Background: Pediatric bone diseases due to osteoclast overactivity have limited therapeutic options. Denosumab, a human monoclonal antibody against RANK-ligand, has been used in the treatment of these conditions despite limited pediatric safety data. Rebound hypercalcemia after denosumab cessation i...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Endocr Soc
Main Authors: Marpuri, Ian, Cheung, Clement C, Moke, Diana J, Ryabets-Lienhard, Anna
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2021
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8089891/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.1439
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!